Rock Point Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-27,935
Closed -$3.46M 72
2019
Q1
$3.46M Sell
27,935
-26,848
-49% -$3.05M 1.63% 25
2018
Q4
$5.52M Sell
54,783
-410
-0.7% -$46.1K 2.83% 14
2018
Q3
$7.04M Sell
55,193
-386
-0.7% -$45.9K 3.14% 16
2018
Q2
$6.01M Buy
55,579
+1,712
+3% +$186K 2.83% 13
2018
Q1
$5.7M Sell
53,867
-460
-0.8% -$53.4K 2.81% 16
2017
Q4
$6.37M Buy
54,327
+316
+0.6% +$35.7K 2.97% 16
2017
Q3
$6.14M Buy
54,011
+766
+1% +$88.4K 2.86% 18
2017
Q2
$6.64M Buy
53,245
+81
+0.2% +$9.6K 3.12% 13
2017
Q1
$6.3M Sell
53,164
-170
-0.3% -$19.3K 3.21% 13
2016
Q4
$5.34M Buy
+53,334
New +$5.72M 2.75% 14

Other funds holding ZBH

Rock Point Advisors's ZBH Position: Q2 2019 in Review

Rock Point Advisors sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 27,935 shares — an estimated $3.46M sold.

Rock Point Advisors first reported a position in ZBH in Q4 2016 and held it in 10 quarters. The position peaked at $7.04M in Q3 2018. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

  • Rock Point Advisors reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
  • Rock Point Advisors sold 27,935 Zimmer Biomet shares in Q2 2019, an estimated $3.46M.
  • Rock Point Advisors first reported a position in Zimmer Biomet in Q4 2016 and held it in 10 quarters.
  • Rock Point Advisors's Zimmer Biomet position peaked at $7.04M in Q3 2018.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Rock Point Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.